Wuxi Pharma Tech Eyes Local Collaboration
This article was originally published in PharmAsia News
Executive Summary
Leading Chinese CRO Wuxi Pharma Tech has partnered with more than 80 major pharmaceutical corporations worldwide in conducting R&D for new drugs. However, it has yet to work with local pharmaceutical enterprises in China, and expressed interest in collaborating with domestic partners. Because of the high cost of R&D outsourcing, local companies mainly produce generic drugs rather than conduct research by R&D outsourcing. Analysts believe the next five years will see China becoming one of the top medical consumers globally, and new CROs are set to change the concept of drug manufacturing in the country. (Click here for more - Chinese Language)